[A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy â©Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].

You, Jing; Yu, Huiming; Song, Maxiaowei; Shi, Chen; Wang, Xiaohang; Zheng, Ye; Yu, Rong; Shi, Anhui; Zhu, Guangying

[A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy â©Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].

You, Jing; Yu, Huiming; Song, Maxiaowei; Shi, Chen; Wang, Xiaohang; Zheng, Ye; Yu, Rong; Shi, Anhui; Zhu, Guangying.

Afiliação

You J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yu H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Song M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Shi C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zheng Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yu R; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Shi A; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhu G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Zhongguo Fei Ai Za Zhi ; 20(1): 28-34, 2017 Jan 20.

Article em Zh | MEDLINE | ID: mdl-28103970

Assuntos

Quimiorradioterapia/métodos; Neoplasias Pulmonares/patologia; Neoplasias Pulmonares/terapia; Radioterapia de Intensidade Modulada; Carcinoma de Pequenas Células do Pulmão/patologia; Carcinoma de Pequenas Células do Pulmão/terapia; Adulto; Idoso; Quimiorradioterapia/efeitos adversos; Cisplatino/efeitos adversos; Cisplatino/uso terapêutico; Intervalo Livre de Doença; Relação Dose-Resposta à Radiação; Etoposídeo/efeitos adversos; Etoposídeo/uso terapêutico; Feminino; Humanos; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/radioterapia; Masculino; Pessoa de Meia-Idade; Dosagem Radioterapêutica; Radioterapia de Intensidade Modulada/efeitos adversos; Segurança; Carcinoma de Pequenas Células do Pulmão/tratamento farmacológico; Carcinoma de Pequenas Células do Pulmão/radioterapia; Fatores de Tempo

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia de Intensidade Modulada / Carcinoma de Pequenas Células do Pulmão / Quimiorradioterapia / Neoplasias Pulmonares Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhongguo Fei Ai Za Zhi Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google